Medical and Pharmaceutical Acurx Pharma shares rise by 29% on new trial for breakthrough antibiotic ‘ibezapolstat’ Investors are optimistic about the therapeutic's potential as a superior alternative for CDI treatment Rowan DunneMarch 11, 2026
Stock News Biopharma companies Evommune and Nektar soar on eczema treatment data Investors were highly intrigued by their successful studies Rowan DunneFebruary 11, 2026